Medicare's New GLP-1 Bridge Program: What Internal Medicine Physicians Need to Know

Medicare's new GLP-1 Bridge Program is reshaping how internal medicine physicians manage coverage, access, and continuity of care for patients on GLP-1 therapies. This webinar breaks down what the program covers, who qualifies, and how the changes affect prescribing decisions and patient counseling in daily practice. Attendees will leave with a clear, practical understanding of the new coverage pathway and what to communicate to patients navigating the transition.

Sponsored by Lilly.

There are no CMEs offered for this webinar.

CME Credit Available:

This activity offers .50 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Discuss diagnosis and treatment of hypothyroidism. 
• Discuss diagnosis and treatment of hyperthyroidism.
• Discuss thyroid eye disease.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

John Sutton, DO, MACOI, FEAA, CCD, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers 1.00 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Identify current screening and diagnostic tests in evaluating a patient with kidney disease 
• Discuss the pathophysiology and cardiovascular comorbidity in chronic kidney disease and the effect of lifestyle modification in the treatment of chronic kidney disease.
• Review current individualized pharmacological treatments to slow the progression of chronic kidney disease and the associated metabolic complications.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Mark Baldwin DO, MACOI, FASN, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Describe appropriate selection and interpretation of dexamethasone suppression testing (DST) 
• Describe various medications to treat cortisol excess
• Describe how to differentiate excess cortisol secretion from pituitary, adrenal, and ectopic sources.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Jack Snitzer, DO, MHA, FACOI, FACE, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

CME Credit Available:

This activity offers .75 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Define different drug reaction.
• Define common drug allergies in hospitalized patients.
• Use both PenFast and SulfaFast systems.

Conflict of Interest Disclosures: 

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert Hostoffer Jr., DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from July 31, 2026, until July 31, 2029.

Overview

ACOI2025 “Top 3 Attendee Favorites” bundle brings together the three most popular lectures from our Annual Meeting in one convenient package:

New AF Guidelines: The Pillars of Therapy Have Changed

Speaker: Israel Henriquez, DO

CME Credits: 0.75 1A AOA

In this session, you'll learn how to:

• Understand cardiac anatomy and electrophysiologic basis of atrial fibrillation.
• Explain the key mechanisms driving atrial fibrillation, including electrical triggers, structural remodeling.
• Apply the latest ACC/AHA/HRS guideline updates to the management of atrial fibrillation.

Financial Disclosure: Israel Henriquez, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Advances & Challenges in the Management of Obesity, MASH, and Related Complications

Speaker: Andrew Buelt, DO

CME Credits: 1.00 1A AOA

In this session, you'll learn how to:

• Critically appraise current and emerging pharmacologic and interventional therapies for obesity.
• Critically appraise current and emerging pharmacologic and interventional therapies for metabolic dysfunction-associated steatohepatitis (MASH).
• Identify ongoing challenges—including therapeutic access, adherence barriers, and disparities in care.

Financial Disclosure: Andrew Buelt, DO, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

When AI Goes Wild: The Unspoken Challenges Facing Modern American Medicine

Speaker: Stephen Ruffenach, DO

CME Credits: 0.50 1A AOA

In this session, you'll learn how to:

• Identify the three foundational flaws—bias, generalizability, and opacity—that create a "cracked foundation" for medical AI.
• Discuss how the legal concept of the "standard of care" is being disrupted, creating a "legal double bind" for clinicians who can be sued for both using and not using AI.
• List and explain the key actions a frontline clinician should take to mitigate personal and professional risk, such as interrogating vendor data, documenting clinical dissent, and engaging with institutional leadership and liability insurers.

Financial Disclosure: Stephen J. Ruffenach, DO, MS, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose. 

CME Credit Available:

This activity offers a total of 2.25 Category 1A AOA credit

Important: CME credit for lectures included in this package cannot be claimed more than once. If you previously claimed CME credit for any of these lectures through attendance at ACOI2025, either online or in person, you are not eligible to claim credit for those lectures again.

Note: ACOI reports credits to the AOA at the beginning of each month.

Pricing:

This exclusive bundle is offered at a special discounted rate, providing a 10% savings compared to purchasing each item individually.

Members: $81.00

Non-Members: $108.00

Residents/Fellows: $27.00

Students: FREE

Release & Review Date: 

This activity is valid from June 17, 2026, until January 1, 2029. A notification will be sent 15 days prior to expiration to remind the registrant of the upcoming end date.

 NOTE: This package's contents will no longer be available to access after January 1, 2029.

ACOI 2025 is the learning experience for osteopathic internists and subspecialists, residents, and students featuring innovative keynote speakers, unique networking opportunities, and the latest advances in subspecialty topics, practice management, and faculty development.

CME Credit Available:

This activity offers a total of 44 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Release & Review Date: 

This activity is valid from January 1, 2026, until January 1, 2029. 

NOTE: This package's contents will no longer be available to access after January 1, 2029.

Pricing:

Members: $945.00

Non-Members: $1,195.00

Residents/Fellows: $250.00

Students: FREE

CME Credit Available:

This activity offers 0.5 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Explain the genetic determinants that influence lipoprotein(a) structure and plasma concentration.
• Describe how recent advances in translational biology have improved understanding of lipoprotein(a)’s role in cardiovascular disease.
• Evaluate emerging clinical trial data assessing novel therapies targeting lipoprotein(a) reduction.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Robert J. Chilton, DO, MACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from January 1, 2026, until January 1, 2029.

CME Credit Available:

This activity offers 0.75 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Demonstrate a basic understanding of the technology behind modern AI tools and recognize which are effective in the clinical setting.
• Apply prompt engineering principles to customize AI outputs for efficient teaching and clinical decision support.
• Use AI tools to rapidly generate chalk talks, discussion questions, and learning points relevant to clinical care.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Erika Abel, MD, Candice Mateja, DO, FACP, Elizabeth Peek, DO, and Elimarys Perez-Colon, MD faculty for this activity, have no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from January 1, 2026, until January 1, 2029.

CME Credit Available:

This activity offers 1 1A AOA 

Note: ACOI reports credits to the AOA at the beginning of each month.

Learning Objectives:

In this session, you'll learn how to:

• Upon completion, participant will be able to define the trajectory-based approach to left ventricular ejection fraction (LVEF) analysis and its impact on decision-making in HFrEF care.
• Upon completion, participant will be able to describe barriers and facilitators to the implementation of quadruple guideline-directed medical therapy in patients with HFrEF.
• Upon completion, participant will be able to describe how to use digital health tools effectively to monitor patient status and optimize therapy adherence in heart failure management.

Conflict of Interest Disclosures:

ACOI requires each planner and presenter to identify all conflicts of interest and mitigates risk of bias using a series of strategies for relevant conflicts. Unless otherwise noted below, the ACOI, ACOI staff and planners for this activity have no relevant financial relationships with ineligible companies to disclose.

Arash Karnama, DO, FACOI, faculty for this activity, has no relevant relationships with ineligible companies to disclose.

Release & Review Date: 

This activity is valid from January 1, 2026, until January 1, 2029.